On this page
Typically prepared by a compounding pharmacy under the direction of a licensed healthcare professional — not an FDA-approved finished product in this form.
Overview
Product & regulatory status
FDA-approved intravenous Carnitor exists for specified metabolic and dialysis-related deficiency. Other compounded routes are separate products.
Carrier function
Carnitine helps transport long-chain fatty acids into mitochondria for oxidation; that role does not imply unlimited benefit from additional exposure. [1]
What the evidence shows
Dialysis evidence measures carnitine exposure
The Carnitor label describes small dialysis studies, including one in 12 patients, showing increased plasma carnitine. It explicitly notes that effects on symptoms and clinical outcomes in this population were not determined by those findings. [1]
Fat transport is not proof of fat loss
An eight-week randomized study in 36 overweight women found no additional weight or fat-mass benefit from oral carnitine with aerobic training. This small oral trial does not determine every possible effect, and cannot validate a compounded injection. [2]
What remains unknown
Whether a particular injectable wellness formulation improves meaningful outcomes in people with adequate carnitine is unestablished. Oral and intravenous exposure are not interchangeable.
Safety
Serious reactions
The injection label reports anaphylaxis, airway swelling and bronchospasm, particularly in dialysis patients. Seizures have also been reported. [1]
Medication interaction
Increased INR has been reported with warfarin. This matters when reviewing the complete medication list. [1]
Approved route distinction
The cited Carnitor product is for intravenous use. Its approval does not establish other compounded injectable preparations as equivalent. [1]
Understanding product quality
Compounded drugs are not FDA-approved finished products. Poor preparation can cause contamination or incorrect strength. A catalog entry or a research paper is not a quality assessment of your product. [3]
When to seek urgent help
Severe allergic symptoms such as trouble breathing, throat or tongue swelling, or fainting need immediate help. Call 911 or your local emergency number. This is general emergency information, not a complete list of risks for this compound. [4]
A starting point for discussion
This is not a complete list of adverse effects or interactions. Your health history, other medicines, and the exact formulation matter. Missing safety data is not evidence of safety.
Common questions
Does its mitochondrial role make it a proven fat burner?
No. A normal metabolic function is different from evidence that supplementation changes body composition.
Which details identify the relevant evidence?
The diagnosed deficiency, product, route and clinical outcome being targeted.
Questions for your clinician
Does the evidence match my condition and this exact product? What risks or interactions matter for me? How would we assess whether it is helping?
Sources
- Carnitor injection prescribing informationUS levocarnitine injection label; inborn-error and dialysis deficiency indications, pharmacokinetic studies and adverse effects.
- Villani et al.: carnitine and weight lossInternational Journal of Sport Nutrition and Exercise Metabolism, 2000; 36 women randomized to oral carnitine or placebo alongside aerobic training.
- Compounding and the FDA: Questions and AnswersFDA · product quality and regulation
- AnaphylaxisMedlinePlus · recognizing an emergency
Educational information, not a recommendation to use a compound. Kairo does not give dosing advice. Review decisions with a licensed healthcare professional.